中国健康心理学杂志
中國健康心理學雜誌
중국건강심이학잡지
HEALTH PSYCHOLOGY JOURNAL
2015年
8期
1152-1154
,共3页
老年心血管病%焦虑情绪%疏肝解郁胶囊%帕罗西汀
老年心血管病%焦慮情緒%疏肝解鬱膠囊%帕囉西汀
노년심혈관병%초필정서%소간해욱효낭%파라서정
Elderly cardiovascular disease%Anxiety%Shugan Jieyu capsule%Paroxetine
目的:探讨疏肝解郁胶囊对老年心血管病患者伴发焦虑情绪的疗效。方法:将88例伴有焦虑情绪的老年心血管病患者随机分为两组,研究组45例,对照组43例。研究组采用疏肝解郁胶囊治疗,对照组采用帕罗西汀治疗。疗效评定采用汉密尔顿焦虑量表( HAMA),主观幸福感评定采用费城老年中心信心量表( PGC),副反应评定采用治疗中需处理的不良反应症状量表( TESS)。结果:①有效率比较:分别为88.4%和94.9%(χ2=0.43,P>0.05);②HAMA比较:两组量表评分较治疗前均降低(P<0.05),但治疗2周后研究组较对照组下降更明显(t=2.4002,P<0.05);③PGC量表比较:治疗8周后两组量表总分及各项因子分均较治疗前明显改善(P均<0.05),但研究组在总分、激越因子、孤独与不满因子较对照组改善明显( t=4.0624,2.7058,2.7306,P均<0.05);④不良反应发生率比较:分别为6.98%和43.59%(t=10.34,P<0.05)。结论:疏肝解郁胶囊对老年心血管病患者伴发焦虑情绪疗效与帕罗西汀疗效相当,不良反应小,适合临床推广使用。
目的:探討疏肝解鬱膠囊對老年心血管病患者伴髮焦慮情緒的療效。方法:將88例伴有焦慮情緒的老年心血管病患者隨機分為兩組,研究組45例,對照組43例。研究組採用疏肝解鬱膠囊治療,對照組採用帕囉西汀治療。療效評定採用漢密爾頓焦慮量錶( HAMA),主觀倖福感評定採用費城老年中心信心量錶( PGC),副反應評定採用治療中需處理的不良反應癥狀量錶( TESS)。結果:①有效率比較:分彆為88.4%和94.9%(χ2=0.43,P>0.05);②HAMA比較:兩組量錶評分較治療前均降低(P<0.05),但治療2週後研究組較對照組下降更明顯(t=2.4002,P<0.05);③PGC量錶比較:治療8週後兩組量錶總分及各項因子分均較治療前明顯改善(P均<0.05),但研究組在總分、激越因子、孤獨與不滿因子較對照組改善明顯( t=4.0624,2.7058,2.7306,P均<0.05);④不良反應髮生率比較:分彆為6.98%和43.59%(t=10.34,P<0.05)。結論:疏肝解鬱膠囊對老年心血管病患者伴髮焦慮情緒療效與帕囉西汀療效相噹,不良反應小,適閤臨床推廣使用。
목적:탐토소간해욱효낭대노년심혈관병환자반발초필정서적료효。방법:장88례반유초필정서적노년심혈관병환자수궤분위량조,연구조45례,대조조43례。연구조채용소간해욱효낭치료,대조조채용파라서정치료。료효평정채용한밀이돈초필량표( HAMA),주관행복감평정채용비성노년중심신심량표( PGC),부반응평정채용치료중수처리적불량반응증상량표( TESS)。결과:①유효솔비교:분별위88.4%화94.9%(χ2=0.43,P>0.05);②HAMA비교:량조량표평분교치료전균강저(P<0.05),단치료2주후연구조교대조조하강경명현(t=2.4002,P<0.05);③PGC량표비교:치료8주후량조량표총분급각항인자분균교치료전명현개선(P균<0.05),단연구조재총분、격월인자、고독여불만인자교대조조개선명현( t=4.0624,2.7058,2.7306,P균<0.05);④불량반응발생솔비교:분별위6.98%화43.59%(t=10.34,P<0.05)。결론:소간해욱효낭대노년심혈관병환자반발초필정서료효여파라서정료효상당,불량반응소,괄합림상추엄사용。
Objective:To investigate the efficacy of Shugan Jieyu capsule on elderly patients with car-diovascular disease associated with anxiety.Methods:88 elderly patients of cardiovascular disease with anxiety were randomly divided into two groups,45 patients in the study group and 43 cases in the control group.Study group using Shugan Jieyu capsule treatment,the control group received paroxetine treatment. Efficacy was assessed using the Hamilton Anxiety Scale( HAMA) ,subjective well-being was assessed u-sing the Philadelphia Geriatric Center confidence Scale( PGC) ,the treatment of side effects was assessed using treatable adverse symptom scale(TESS).Results:① Efficiency comparison:respectively,88.4%and 94.9%(χ2 =0.43,P>0.05).②HAMA comparison:After treatment,the scores of two groups were lower than before treatment(P<0.05);however,two weeks after treatment,the scores decreased more in the study group than in the control group(t=2.4002,P<0.05).③PGC scale comparison:After 8 weeks of treatment,total score and factor scores in both groups improved significantly(P<0.05),however,the study group had more improvement in the total score,agitation factor,loneliness and dissatisfaction factor than the control group(t=4.0624,2.7058,2.7306;P<0.05).④ Incidence of adverse reactions:Re-spectively 6.98%and 43.59%(t=10.34,P<0.05).Conclusion:Shugan Jieyu capsule has the same effect on elderly patients with cardiovascular disease associated with anxiety efficacy as paroxetine;both have small adverse reactions,and are suitable for clinical use.